Company News

Share this article:
Boehringer Ingelheim will buy much of Wyeth's Fort Dodge Animal Health business when Pfizer's acquisition of Wyeth closes. In the US and Canada, Boehringer Ingelheim would own and market Wyeth's pet and cattle vaccine lines as well as a range of drugs for pets, cattle and other species, including several swine vaccines in Canada.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions